Setipafant

Drug Profile

Setipafant

Alternative Names: BN 50727

Latest Information Update: 09 Jun 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ipsen
  • Class Antiplatelets; Cytoprotectives
  • Mechanism of Action Platelet activating factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Crohn's disease; Diarrhoea; Inflammatory bowel diseases; Peptic ulcer; Ulcerative colitis

Most Recent Events

  • 31 May 2003 Beaufour-Ipsen is now called Ipsen
  • 16 Jul 1996 Discontinued-II for Ulcerative colitis in France (Unknown route)
  • 16 Jul 1996 Discontinued-Preclinical for Crohn's disease in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top